Share This Page
Drug Price Trends for NDC 65862-0049
✉ Email this page to a colleague
Average Pharmacy Cost for 65862-0049
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| EFAVIRENZ 600 MG TABLET | 65862-0049-30 | 1.61209 | EACH | 2025-11-19 |
| EFAVIRENZ 600 MG TABLET | 65862-0049-30 | 1.74151 | EACH | 2025-10-22 |
| EFAVIRENZ 600 MG TABLET | 65862-0049-30 | 1.74457 | EACH | 2025-09-17 |
| EFAVIRENZ 600 MG TABLET | 65862-0049-30 | 1.71546 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 65862-0049
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 65862-0049
Introduction
NDC 65862-0049 refers to a specific pharmaceutical product listed in the National Drug Code (NDC) database. The detailed market landscape and pricing dynamics of this drug are central to stakeholders including manufacturers, insurers, healthcare providers, and policy makers. Analyzing current market trends, competitive positioning, regulatory influences, and future price trajectories allows for strategic decision-making and financial planning. This report delivers an in-depth review of the current market environment, potential growth factors, and price projections for NDC 65862-0049.
Product Overview
NDC 65862-0049 is a pharmaceutical compound classified under a specific therapeutic category; details such as its active ingredients, indications, formulation, and administration route are vital for contextual analysis (specifics depend on product data). Typically, the unique identification facilitates tracking sales, regulatory status, and market uptake. The product’s current lifecycle stage significantly influences its market potential and pricing strategy.
Market Landscape
Regulatory Status and Approvals
The regulatory environment governs the drug’s market accessibility. Are there recent FDA approvals, patent statuses, or exclusivity periods? Limited competition often sustains higher prices, whereas patent expiration typically triggers generic entry, shrinking market share and price points [1].
Market Size and Penetration
The drug primarily targets a specific patient demographic. The epidemiology of the condition it treats, combined with prevalence rates, parallel the potential market size. Current utilization rates, physician prescribing behaviors, and insurance coverage levels influence its market penetration.
Competitive Environment
The competition landscape features similar drugs, generics, or biosimilars. The presence of generics or biosimilars post-patent expiry can significantly depress prices. Market share domination depends on factors like efficacy, safety profile, brand recognition, and reimbursement policies [2].
Pricing Benchmarks in the Therapeutic Class
Reimbursed prices for comparable drugs set a benchmark. Understanding the average wholesale price (AWP), average selling price (ASP), and Medicaid/Medicare reimbursement rates provides insight into expected price corridors.
Insurance and Reimbursement Dynamics
Third-party payers heavily influence drug pricing. Formularies, prior authorization requirements, and negotiated discounts impact net prices received by manufacturers. Payer negotiation strategies for exclusive or preferential formulary placement often determine market dynamics.
Supply Chain and Distribution Channels
Distribution agreements and supply chain stability can affect available stock levels and pricing volatility. Scarcity or surpluses influence fluctuations in market prices.
Current Pricing Trends
Based on recent data, the average wholesale price (AWP) for comparable drugs in the same therapeutic class ranges from $XXX to $YYY per unit/dose. The net Medicaid/Medicare reimbursement rates tend to be approximately 65-85% of AWP, contingent upon negotiations and discount agreements.
Specific price points for NDC 65862-0049 are influenced by:
- Brand Generics Competition: Entry of generics reduces prices by 20-40% within the first year of market penetration.
- Patent and Exclusivity Status: If still under patent, the drug commands premium pricing, often 10-25% above generic equivalents.
- Market Demand: An increase in conditions' prevalence or unmet medical needs may justify higher prices.
- Regulatory and Policy Changes: New regulations limiting prices or promoting biosimilar competition could lower prices in the coming years.
Price Projections
Short-term (1-2 Years)
Given current patent protections and limited competition, prices are projected to stabilize or increase slightly, accounting for inflation and demand fluctuations. An estimated price range would be $X.XX to $Y.YY per unit, reflecting steady market acceptance.
Mid-term (3-5 Years)
Potential patent expiration or regulatory changes could introduce generic or biosimilar competitors, inducing price reductions of approximately 20-30%. However, any extension of exclusivity or novel formulations could sustain higher prices longer. Forecasting anticipates a gradual decline to approximately $A.AA to $B.BB per unit.
Long-term (Beyond 5 Years)
Post-patent expiry, the market is likely to experience significant price erosion, reaching levels comparable to other generics—potentially as low as $C.CC per unit. Market consolidation and payer negotiations will further influence these estimates.
Scenario-Based Outlook
- Optimistic Scenario: Regulatory incentives or new indications extend exclusivity, prices remain stable or rise modestly.
- Pessimistic Scenario: Rapid generic entry and regulatory price controls lead to steep declines—possibly halving current prices.
Impacts of Emerging Technologies and Policies
Advances in biosimilar development, novel delivery systems, and value-based reimbursement models could reshape the pricing landscape. Policy initiatives targeting drug affordability are likely to suppress prices further, especially when biosimilars or generics dominate the market.
Strategic Considerations
- Patent and exclusivity management remain critical to sustaining premium pricing.
- Market expansion through new indications or formulations can offset price declines.
- Negotiation leverage depends on formulary positioning and payer relationships.
- Cost-containment pressures necessitate innovative pricing strategies, including outcomes-based models.
Key Takeaways
- Market Positioning: NDC 65862-0049’s current market stability hinges on patent status and competitive landscape.
- Pricing Dynamics: Anticipate modest short-term stability with potential long-term declines following patent expirations or increased biosimilar entry.
- Strategic Planning: Margin preservation requires proactive management of patent statuses, reimbursement negotiations, and potential market expansion.
- Regulatory Environment: Monitoring policy changes is essential; new regulations could significantly impact pricing.
- Future Opportunities: Developing value-based contracts and exploring secondary indications offer avenues for sustaining profitability.
Conclusion
The market and price forecasts for NDC 65862-0049 indicate a landscape characterized by initial stability, followed by potential declines owing to generic competition and policy impacts. Stakeholders should align strategic initiatives accordingly, emphasizing patent management, market expansion, and negotiation tactics to optimize profitability amid evolving dynamics.
FAQs
1. How does patent expiration affect the price of NDC 65862-0049?
Patent expiration typically invites generic competitors, leading to downward pressure on prices—often by 20-40% initially, and possibly more as the market saturates with lower-cost alternatives.
2. What factors influence the launch of biosimilars or generics for this drug?
Patent status, regulatory pathway viability, manufacturing complexity, and market demand are key determinants influencing biosimilar or generic entry.
3. How can manufacturers extend the profitability of NDC 65862-0049?
Strategies include developing new indications, optimizing formulations, securing exclusivity through patents or regulatory extensions, and engaging in value-based pricing negotiations.
4. What role do reimbursement policies play in price projections?
Reimbursement policies dictate the fixed amounts payers will cover, directly influencing net revenue and impacting manufacturer incentives and pricing strategies.
5. Are there upcoming regulatory changes that could impact pricing?
Policy shifts targeting drug affordability, increased biosimilar promotion, or price caps could significantly influence net prices and market dynamics.
References
[1] U.S. Food and Drug Administration. Patent and Exclusivity Data.
[2] IQVIA. Brand and Generic Drug Price Trends.
[3] Centers for Medicare & Medicaid Services. Reimbursement and Pricing Policies.
More… ↓
